Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer.
about
Structural Mechanisms Determining Inhibition of the Collagen Receptor DDR1 by Selective and Multi-Targeted Type II Kinase InhibitorsDiscoidin domain receptor tyrosine kinases: new players in cancer progressionHigh expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma.Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.Integrin signaling in cancer cell survival and chemoresistanceDiscoidin domain receptor 1 activity drives an aggressive phenotype in bladder cancer.Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis.Discoidin domain receptor 1: New star in cancer-targeted therapy and its complex role in breast carcinoma.Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancers.Discoidin domain receptors: a promoter of the aggressive behavior of ameloblastomas.Silencing of Discoidin Domain Receptor-1 (DDR1) Concurrently Inhibits Multiple Steps of Metastasis Cascade in Gastric Cancer.Collagen type 1 promotes survival of human breast cancer cells by overexpressing Kv10.1 potassium and Orai1 calcium channels through DDR1-dependent pathway.miR-199b-5p inhibits triple negative breast cancer cell proliferation, migration and invasion by targeting DDR1
P2860
Q27683558-CB92805D-FD8F-4CF1-B583-45164B4354C9Q35957518-A541F573-BF9D-4274-BECA-F74CADE213B7Q35986858-C24C50A2-0E8C-40FE-8439-3496ADE95ACFQ36265839-31B6523A-DF14-4598-8E37-D591DD0D8D3EQ38737103-876E300C-1DEA-489B-84D7-959D04853937Q38748552-E8EC950A-6EF9-4239-9160-3132CB716072Q40120259-D194D013-4532-4217-8125-51BEB0EE0399Q42198719-703946E9-77FC-4F18-B7B8-AD9DCC896C0DQ42241972-56CF0357-085D-4559-8FD6-14EC53392954Q49658859-E4A41B20-D47A-4A2B-83CE-E11EF240278BQ50223387-73D8EBBF-80F5-4B53-B5FD-A93FDCEACFD7Q52730273-96102DF1-4EFF-42A2-B073-D38AE9A07896Q54360787-AA8CA89E-B813-4961-8028-2A9D728B9A78Q55097289-5101231B-6780-4999-BA22-72354A97AEC0Q55263775-54725CC0-B56E-4676-BCF3-3AE1CD1ED6DEQ58802696-C88FBA06-49E0-4422-B92C-D626C189BBF7
P2860
Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of receptor tyr ...... ker for serous ovarian cancer.
@ast
Identification of receptor tyr ...... ker for serous ovarian cancer.
@en
Identification of receptor tyr ...... ker for serous ovarian cancer.
@nl
type
label
Identification of receptor tyr ...... ker for serous ovarian cancer.
@ast
Identification of receptor tyr ...... ker for serous ovarian cancer.
@en
Identification of receptor tyr ...... ker for serous ovarian cancer.
@nl
prefLabel
Identification of receptor tyr ...... ker for serous ovarian cancer.
@ast
Identification of receptor tyr ...... ker for serous ovarian cancer.
@en
Identification of receptor tyr ...... ker for serous ovarian cancer.
@nl
P2093
P2860
P356
P1476
Identification of receptor tyr ...... rker for serous ovarian cancer
@en
P2093
Jinhua Quan
Kenichi Tanaka
Sosuke Adachi
Tetsuro Yahata
P2860
P304
P356
10.3390/IJMS12020971
P407
P577
2011-01-31T00:00:00Z